CLINICAL_TRIALS
trial_result
· 2013-08-08
Clinical Trial Update: A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma [Phase 2]
Summary
Phase 2 trial investigating erlotinib in combination with radiotherapy for cutaneous squamous cell carcinoma has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-08